4Warren S,Gates O.Multiple primary malignant tumors:a survey of the literature and statistical study[J].Am J Cancer,1932,51(16):1358-1361.
5Tsai ST,Jin YT,Su IJ.Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization.A correlation with WHO histologic subtypes[J].Cancer,1996,77(2):231-236.
6Griffin BE.Epstein-Barr virus(EBV) and human disease:facts,opinions and problems[J].Mutat Res,2000,462(2-3):395-405.
7Fina F,Romain S,Ouafik L,et al.Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas[J].Br J Cancer,2001,84(6):783-790.
8Deshpande CG,Badve S,Kidwai N,et al.Lack of expression of the Epstein-Barr virus(EBV) gene products,EBERs,EBNa1,LMP1,and LMP2A,in breast cancer cells[J].Lab Invest,2002,82(9):1193-1199.
9Yan J,Fang Y,Huang BJ,et al.Absence of evidence for HER2 amplification in nasopharyngeal carcinoma[J].Cancer Genet Cytogenet,2002,132(2):116-119.
10Rovatti M, Gerosa E, Turi V, et al. Multiple primary malignant neoplasms [J]. Minerva Chir,1995, 50(11) : 949-958.
